NDC product
Top Value Effervescent Cold Relief
NDC 50201-7682 · Tower Laboratories Ltd
Key facts
| Product NDC | 50201-7682 |
|---|---|
| Proprietary name | Top Value Effervescent Cold Relief |
| Nonproprietary name | Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate |
| Substances | ASPIRIN, PHENYLEPHRINE BITARTRATE, CHLORPHENIRAMINE MALEATE |
| Dosage form | TABLET, EFFERVESCENT |
| Route | ORAL |
| Labeler | Tower Laboratories Ltd |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE] and 5 more |
| Marketing start | Jul 1, 2010 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: